Endovascular simulation solutions

Facts as of March 31, 2021
NET SALES
14,7%
EBIT
january-march -15 Msek
ACQUISITION
TIME
2019
BURE'S OWNERSHIP STAKE
14,7%
REPRESENTATION
FROM BURE
Gösta Johannesson (Member of the board)
NET ASSET VALUE
311 Msek
SHARE OF BURE'S NET ASSET VALUE
1,8 %

Mentice is a world leader in software and hardware simulation solutions for endovascular therapies (vascular surgery). The solutions assist healthcare professionals in learning, retaining and improving their skills and thereby increasing their productivity and results. The Mentice solutions are scientifically validated and developed specifically for healthcare providers and the medical devices industry. Mentice is the global market leader in this area.